3Mariani L, Sandri MT, Preti M, et al. HPV-testing in follow- up of patients treated for CIN2+ lesions[J]. J Cancer, 2016, 7 (1) : 107-114.
4Shaikh MH, McMillan NA, Johnson NW. HPV-associated head and neck cancers in the Asia Pacific: A critical literature review meta-analysis[J]. Cancer Epidemiol, 2015, 39(6): 923-938.
5Keim-Malpass J, Mitchell EM, Camaeho F. HPV vaccination series completion and co-vaccination: Pairing vaccines may matter for adolescents [J]. Vaccine, 2015, 33 ( 43 ) : 5729- 5732.
6Takes RP, Wierzbicka M, D'Souza G, et al. HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs [J]. Oral Oncol, 2015, 51 (12) : 1057-1060.
7Whang SN, Fili ppova M, Duerksen-Hughes P. Recent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Assoeiated Head and Neck Cancer[J]. Vi- ruses, 2015, 7(9): 5040-5065.
8Mirghani H, Amen F, Tao Y, et al. Increased radiosensitivity of HPV-positive head and neck cancers: Molecular basis and therapeutic perspectives[J]. Cancer Treat Rev, 2015, 41(10) : 844-852.
9Pullos AN, Castilho RM, Squarize CH. HPV Infection of the Head and Neck Region and Its Stem Cells[J]. J Dent Res, 2015, 94(11): 1532-1543.
10Boscolo-Rizzo P, Pawlita M, Holzinger D. From HPV positive towards HPV-driven oropharyngeal squamous cell carcinomas[J].Cancer Treat Rev, 2016, 42(1): 24- 29.
